Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Gilead Sciences Inc (NASDAQ: GILD)

$67.26 USD $0.16 (0.24%)
Last Price $67.26
Net Change $0.16 (0.24%)
Bid $66.74
Ask Price $67.81
Open Price $67.1
Previous Close Price $67.1
High Price $67.57
Low Price $66.91
Number of Trades 36,358
Volume 7,224,700
Fifty Two Week High $103.1 (2016-04-26)
Fifty Two Week Low $65.38 (2017-02-09)
Average Daily Volume 10,631,182
Share Outstanding 1,307,070 Shares
Total Dividend Payout 2.08/yr
Dividend Yield 3.1%
1st Quarter Earnings $2.7 (2017-02-07)
2nd Quarter Earnings $2.75 (2016-11-01)
3nd Quarter Earnings $3.08 (2016-07-25)
4th Quarter Earnings $3.03 (2016-04-28)
PE Ratio $5.91
EPS Growth $-29.64
Recent Earnings $2.7
Annual EPS $11.35
Last Quarter EPS $
Market Capitalization $87.91B
Insider Shareholders % 0.014%
Annual Revenue $0B
No. Shares Outstanding 1,307,070
Inst. Shareholder % 75.86%
Annual Net Income $13.5B
TTM Net Profit Margin $44.43
1-Year Return -24.96%
3-Year Return -0.97%
5-Year Return 187.68%
5-Year Revenue Growth 262.42%
5-Year Earnings Growth 521.31%
5-Year Dividend Growth 0%
Annual Dividend $2.08
Annual Dividend Yield 3.1%
Change in EPS YTD -29.639999%
Dividends per Share $0.52
Stock Split Ratio 2-1
Beta 1.15
Gilead Sciences, Inc. is an independent biopharmaceutical company that seeks to provide accelerated solutions for patients and the people who care for them. They have a broad-based focus on developing and marketing drugs to treat patients with infectious diseases, including viral infections, fungal infections and bacterial infections, and a specialized focus on cancer. They have expertise in liposomal drug delivery technology, a technology that the company uses to develop drugsthat are safer, easier for patients to tolerate and more effective.

Today's Gilead Sciences Stock Update

There aren't enough hours in the day to get a detailed look at your favorite investments, like Gilead Sciences stock. So here's a quick look at GILD's most important numbers right now (for March 30, 2017). Gilead Sciences shares rose 0.24% or $0.16 from the day before, taking the Gilead Sciences closing price to $67.26. So where does that put Gilead Sciences stock relative to the past year of prices? GILD is now trading at a lower price than it was one-year ago, with the stock price having slipped 27.26% since then.

BREAKING: How a 26(f) Program Can Save Your Retirement

The Gilead Sciences stock price 52-week high is $103.10. That was hit on 4/26/2016. The GILD stock 52-week low is $65.38, reached on 2/09/2017. And, take note - GILD trading volume yesterday was 8,509,101. That's more than Gilead Sciences stock's average daily trading volume of 7,224,725. The market cap of Gilead Sciences is 87,913,528,000. That means Gilead Sciences has a large market cap, because it's between 10 billion and 200 billion. As of April 1, 2016, the company with the biggest market cap of all publicly traded companies is Apple.

TRENDING: The Best Stocks to Buy Now

The current P/E (price/earnings) ratio of Gilead Sciences stock is 5.95. That's less than the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare GILD to other companies in the same industry. The current EPS (earnings per share) of GILD is 9.94. Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Gilead Sciences is 1.15. Gilead Sciences stock has a dividend yield of 3.10%. When the dividend yield is over 2%, the stock is a good consideration for income investors. That yield is what most investors look for when hunting for dividend stocks. For more info on Gilead Sciences stock, check out all the free content we give you at Money Morning. You'll find GILD stock news and coverage on dozens of other key stocks, updated daily.

UP NEXT: These Are the Top 5 Marijuana Stocks to Watch in 2017 - Don't Miss This Sector's Staggering Profit Potential

Click here to read more stories